HLA-E-VL9 antibodies enhance NK cell and CD8 + T cell cytotoxicity against HIV-infected CD4 + T cells.
Hwang JK., Marston DJ., Tuyishime M., Yang H., Wrapp D., Li D., Brackenridge S., Frazier M., Rhodes B., Harris C., Quastel M., Kapingidza AB., Kliszczak AE., Gater J., Borrow P., Ferrari G., Gillespie GM., McMichael AJ., Haynes BF., Azoitei ML.